{
    "2021-04-27": [
        [
            {
                "time": "",
                "original_text": "医药生物板块涨0.46% 未名医药和双鹭药业涨停",
                "features": {
                    "keywords": [
                        "医药生物",
                        "未名医药",
                        "双鹭药业",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中信证券：安图生物业绩恢复高增长符合预期，公司长期发展前景良好",
                "features": {
                    "keywords": [
                        "中信证券",
                        "安图生物",
                        "业绩恢复",
                        "高增长",
                        "长期发展",
                        "前景良好"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "八大券商主题策略：“药”不能停！业绩炸裂的一季报 只是开始不是结束",
                "features": {
                    "keywords": [
                        "券商",
                        "主题策略",
                        "医药",
                        "业绩炸裂",
                        "一季报",
                        "开始"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "安图生物(603658)：装机量显着增加 业绩逐步恢复",
                "features": {
                    "keywords": [
                        "安图生物",
                        "装机量",
                        "显着增加",
                        "业绩逐步恢复"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}